Comparing Abilify Maintena vs Caplyta
| Abilify Maintena (aripiprazole) | Caplyta (lumateperone) |
|
|---|
| Abilify Maintena (aripiprazole) | Caplyta (lumateperone) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bipolar Disorder, Schizophrenia. Abilify Maintena may also be used for purposes not listed in this medication guide. |
Prescription only
Caplyta is an atypical antipsychotic that is used to treat adults with schizophrenia or depression associated with bipolar disorder. Sleepiness is the most common side effect and it should not be... View more |
Related suggestions Bipolar Disorder
Schizophrenia
|
|||||||||||||||
| More about Abilify Maintena (aripiprazole) | More about Caplyta (lumateperone) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Abilify Maintena has an average rating of 6.3 out of 10 from a total of 71 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 27% reported a negative effect. |
Caplyta has an average rating of 6.7 out of 10 from a total of 192 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 28% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Abilify Maintena side effects |
View all Caplyta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Abilify Maintena prices |
View all Caplyta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other aripiprazole brands include: Abilify, Abilify Asimtufii, Abilify MyCite, Aristada, Aristada Initio, Mezofy, Opipza |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
146 hours |
18 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 736 drugs are known to interact with Abilify Maintena:
|
A total of 609 drugs are known to interact with Caplyta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
December 20, 2019 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.